Serum Amyloid A 4 (SAA4) (Middle Region) Peptide
SAA4
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SAA4 products
- SAA4 (Serum Amyloid A 4 (SAA4))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SAA4 antibody (Catalog #: ARP42300_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SAA4 (Serum Amyloid A 4 (SAA4))
- Synonyms
- C-SAA Peptide, CSAA Peptide, serum amyloid A4, constitutive Peptide, SAA4 Peptide
- Background
-
SAA4 is a major acute phase reactant. It is an Apolipoprotein of the HDL complex.
Alias Symbols: C-SAA, CSAA
Protein Interaction Partner: COL4A1,NUDT9P1
Protein Size: 130 - Molecular Weight
- 2 kDa
- Gene ID
- 6291
- NCBI Accession
- NM_006512, NP_006503
- UniProt
- P35542
-
You are here:
